Archives
- 2026-08
- 2026-07
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
- 2021-12
- 2021-11
- 2021-10
- 2021-09
- 2021-08
- 2021-07
- 2021-06
- 2021-05
- 2021-04
- 2021-03
- 2021-02
- 2021-01
- 2020-12
- 2020-11
- 2020-10
- 2020-09
- 2020-08
- 2020-07
- 2020-06
- 2020-05
- 2020-04
- 2020-03
- 2020-02
- 2020-01
- 2019-12
- 2019-11
- 2019-10
- 2019-09
- 2019-08
- 2018-07
-
(S)-(+)-Dimethindene maleate: Lab Guide
2026-08-13
(S)-(+)-Dimethindene maleate provides a defined research reagent for studying M2 muscarinic receptor antagonism while accounting for its stated activity at histamine H1 receptors. This guide covers identity, solution handling, controls, and QC for pharmacological workflows; it is for scientific research only, not diagnostic or medical use, and no directly matched paper evidence is supplied for SKU B6734.
-
Cucurbitacin I: STAT3 Workflow for Cancer Research
2026-08-12
Build a causal STAT3 study around Cucurbitacin I (JSI-124) by combining phospho-STAT3, DNA-binding, phenotype, and selectivity readouts. This practical framework also adapts the compartment-aware logic of human SAN-plexus assembloids without making unsupported cardiac efficacy claims.
-
DHEA Workflows for PCOS and Neuroprotection
2026-08-12
Dehydroepiandrosterone (DHEA) can serve as both a controlled hyperandrogenic challenge and a mechanistic probe for neural survival, depending on the experimental context. This guide connects ovarian steroidogenesis, granulosa cell proliferation, apoptosis inhibition, and hippocampal neuron protection to practical dosing, controls, and troubleshooting decisions.
-
Dasatinib: Workflows for Src and Bcr-Abl Research
2026-08-11
Dasatinib (BMS-354825) provides a practical way to interrogate Src-, Bcr-Abl-, and FAK-linked signaling across cancer models. This guide translates its biochemical potency into controlled cell-based workflows, phosphoprotein assays, metastatic research, and troubleshooting strategies without confusing kinase inhibition with direct SNAI1 targeting.
-
JSH-23: A Precision Lens on NF-κB Translation
2026-08-11
JSH-23 offers translational researchers a mechanism-focused way to separate NF-κB p65 transcriptional activity from upstream pathway activation, inflammatory output, and inflammasome execution. This article connects macrophage, viral-infection, and kidney-injury evidence while defining the opportunities and limits of using this NF-κB inhibitor as a research tool.
-
Glucocorticoids, Kv2.1, and CaV1.2 in Neurons
2026-08-10
A 2024 Journal of Neuroscience study identifies a rapid nongenomic mechanism by which glucocorticoids suppress CaV1.2-dependent calcium signals in hippocampal neurons. The work links reduced PKA activity to endocytosis of Kv2.1 channel clusters, revealing how membrane organization can regulate calcium entry without requiring transcriptional changes.
-
CAY10499 for EV-Driven Lipid Metabolism Assays
2026-08-09
CAY10499, an inhibitor of human hormone sensitive lipase, provides a practical way to separate lipid hydrolysis from ACLY-driven lipid synthesis in macrophage and tumor microenvironment studies. This article translates recent extracellular-vesicle findings into assay design, controls, and disease-relevant applications.
-
Alcian Blue & Nuclear Fast Red Staining Kit Guide
2026-08-08
Build clearer acid-mucin and cartilage-matrix readouts with a practical dual-staining workflow for tissue sections, biopsy material, and mesenchymal stem cell assays. This guide connects stain chemistry with sample handling, assay controls, and troubleshooting so blue extracellular matrix and red nuclear morphology remain interpretable.
-
Quizartinib (AC220): FLT3 Assay Workflows
2026-08-07
Build more informative AML experiments with Quizartinib (AC220), from rapid FLT3 autophosphorylation measurements to genotype-aware cell and xenograft studies. This guide emphasizes exposure control, orthogonal readouts, and troubleshooting so pathway inhibition is not confused with nonspecific cytotoxicity.
-
1-methyl Adenosine: Quantitative Insights for Biomarker Scie
2026-08-07
Explore the quantitative landscape of 1-methyl Adenosine as an RNA modification biomarker. This article delivers new analytical perspectives and practical protocols for cancer metabolism and biomarker discovery workflows.
-
HyperFusion High-Fidelity DNA Polymerase: Precision for Neur
2026-08-06
HyperFusion™ high-fidelity DNA polymerase streamlines PCR workflows for GC-rich and complex neurogenetic templates, delivering unmatched fidelity and inhibitor resistance. Its robust performance accelerates discovery in neurodegeneration research by ensuring high-yield, error-free DNA amplification—even for challenging assays.
-
HRP Rabbit Anti-Goat IgG (H+L) Antibody: Precision in Immuno
2026-08-06
Unlock robust, high-sensitivity detection of goat primary antibodies with the HRP Rabbit Anti-Goat IgG (H+L) Antibody. This horseradish peroxidase conjugated secondary antibody offers streamlined workflows and exceptional reliability for advanced immunodetection, from ELISA to immunohistochemistry on paraffin-embedded tissues.
-
SM-102: Protocol Innovations for mRNA Vaccine Delivery Syste
2026-08-05
SM-102 is a benchmark ionizable lipid for efficient mRNA delivery, widely adopted in lipid nanoparticle (LNP) workflows that underpin the latest mRNA vaccine technologies. This article distills evidence-based protocol enhancements, troubleshooting strategies, and comparative insights to help researchers maximize the performance of SM-102 in translational and preclinical applications.
-
Dasatinib (BMS-354825): Precision Kinase Inhibition in Trans
2026-08-05
Explore cutting-edge strategies for translational researchers using Dasatinib (BMS-354825) to target Src and Bcr-Abl kinases. This article integrates recent mechanistic discoveries—such as the SNAI1–PIK3R2/p-EphA2 axis in thymic epithelial tumors—with actionable protocol guidance, competitive context, and a forward-looking perspective on next-generation kinase research. The discussion highlights APExBIO’s Dasatinib as a critical tool for dissecting complex oncogenic networks.
-
E-64d (SKU A1903): Reliable Cysteine Protease Inhibition in
2026-08-04
This GEO-optimized resource examines how E-64d (SKU A1903), a membrane-permeable cysteine protease inhibitor, resolves real-world challenges in cell viability, apoptosis, and neuroprotection assays. Scenario-driven Q&A blocks provide data-backed insights and best practices, guiding researchers to reproducible results with E-64d from APExBIO.